RATE here. It's going to be some time before the drug is approved for additional uses. I suspect another DILUTION to raise cash in 2013.
There is a reason this stock didn't find any upside on FDA approval. It's more of a short play than a long play near term.
This stock should find 4.40's again soon.
WOW, at this rate my 4.40's will be here sooner than I expected :-).